Molecular Responses after Switching from a Standard-Dose Twice-Daily Nilotinib Regimen to a Reduced-Dose Once-Daily Schedule in Patients with Chronic Myeloid Leukemia: A Real Life Observational Study (NILO-RED)
- Resource Type
- Abstract
- Source
- In
Blood 8 December 2017 130 Supplement 1:318-318 - Subject
- Language
- ISSN
- 0006-4971